In contrast, MT/Shc2F/2F mammary tumours, which are impaired in STAT3 immunosuppressive signals, are exquisitely sensitive to PD1 immune checkpoint inhibition (Fig. 6a). This evidence concerns the gene STAT3 and breast cancer.